These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6682990)

  • 1. Propranolol in schizophrenia.
    Sethi BB; Dubé S
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):89-99. PubMed ID: 6682990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextro-propranolol and depressive symptoms in a schizophrenic population.
    Manchanda R
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(5):625-32. PubMed ID: 3321153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic effect of propranolol on chronic schizophrenics: study of a gradual treatment regimen.
    Elizur A; Segal Z; Yeret A; Davidson S; Atsmon A
    Psychopharmacology (Berl); 1979 Jan; 60(2):189-94. PubMed ID: 34185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol in chronic schizophrenia: a controlled study in neuroleptic-treated patients.
    Lindström LH; Persson E
    Br J Psychiatry; 1980 Aug; 137():126-30. PubMed ID: 6107136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of propranolol and thioridazine on positive and negative symptoms of schizophrenia.
    Eccleston D; Fairbairn AF; Hassanyeh F; McClelland HA; Stephens DA
    Br J Psychiatry; 1985 Dec; 147():623-30. PubMed ID: 3913486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings.
    Hanssen T; Heyden T; Sundberg I; Alfredsson G; Nybäck H; Wetterberg L
    Arch Gen Psychiatry; 1980 Jun; 37(6):685-90. PubMed ID: 7387339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose propranolol in schizophrenia.
    Sheppard GP
    Br J Psychiatry; 1979 May; 134():470-6. PubMed ID: 476356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistant schizophrenia: what chemotherapy?].
    Vanelle JM
    Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434
    [No Abstract]   [Full Text] [Related]  

  • 9. Propranolol in the control of schizophrenic symptoms.
    Yorkston NJ; Zaki SA; Malik MK; Morrison RC; Havard CW
    Br Med J; 1974 Dec; 4(5945):633-5. PubMed ID: 4441828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response of lymphocyte beta-adrenergic receptors to chronic propranolol treatment in depressed patients, schizophrenic patients, and normal controls.
    Zohar J; Bannet J; Drummer D; Fisch R; Epstein RP; Belmaker RH
    Biol Psychiatry; 1983 May; 18(5):553-60. PubMed ID: 6305430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses].
    Chabannes JP; Pelissolo A; Farah S; Gerard D
    Encephale; 1998; 24(4):386-92. PubMed ID: 9809244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextro-propranolol in schizophrenia.
    Hirsch SR; Manchanda R; Weller MP
    Prog Neuropsychopharmacol; 1980; 4(6):633-7. PubMed ID: 7220678
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
    Martín J; Gómez JC; García-Bernardo E; Cuesta M; Alvarez E; Gurpegui M
    J Clin Psychiatry; 1997 Nov; 58(11):479-83. PubMed ID: 9413413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mianserin in chronic schizophrenia.
    Mizuki Y; Kajimura N; Kai S; Suetsugi M; Ushijima I; Yamada M
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):517-28. PubMed ID: 1641495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some clinical and metabolic aspects of propranolol in chronic schizophrenia.
    King DJ; Turkson SN; Liddle J; Kinney CD
    Br J Psychiatry; 1980 Nov; 137():458-68. PubMed ID: 7008891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of propranolol treatment on serum prolactin level in schizophrenic patients.
    Elizur A; Segal Z; Yeret A; Ben-David M
    Commun Psychopharmacol; 1980; 4(3):203-6. PubMed ID: 7226751
    [No Abstract]   [Full Text] [Related]  

  • 17. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma prolactin levels before and during propranolol treatment in chronic schizophrenia.
    Wilson JD; King DJ; Sheridan B
    Br J Clin Pharmacol; 1979 Mar; 7(3):313-4. PubMed ID: 427008
    [No Abstract]   [Full Text] [Related]  

  • 19. Safeguards in the treatment of schizophrenia with propranolol.
    Yorkston NJ; Zaki SA; Themen JF; Havard CW
    Postgrad Med J; 1976; 52 Suppl 4():175-80. PubMed ID: 967774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group.
    Chouinard G; Kopala L; Labelle A; Beauclair L; Johnson SV; Singh KI
    Can J Psychiatry; 1998 Dec; 43(10):1018-25. PubMed ID: 9868567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.